In his weekly clinical update, Dr. Griffin discusses monkeypox and chickenpox co-infection in southern Nigeria, vaccine effectiveness against influenza A, SARS-CoV-2 neutralizing antibody titers in maternal blood, umbilical cord blood, and breast milk, COVID-19 rapid antigen tests with self-collected vs health care worker–collected nasal and throat swab specimens, four methods for monitoring SARS-CoV-2 and Influenza A virus activity in schools, efficacy and safety of Baricitinib for the treatment of hospitalized adults with COVID-19, a synbiotic preparation (SIM01) for post-acute COVID-19 syndrome in Hong Kong, consistent absence of cerebrospinal fluid biomarker abnormalities in patients with neurocognitive post-COVID complications, and risk of new-onset long COVID following reinfection with SARS-CoV-2.

Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email

Become a patron of TWiV!

Links for this episode

• Monkeypox and chickenpox co-infection in southern Nigeria (JID)
• Vaccine effectiveness against influenza A (CID)
• SARS-CoV-2 neutralizing antibody titers in maternal blood, umbilical cord blood, and breast milk (JOP)
• COVID-19 rapid antigen tests with self-collected vs health care worker–collected nasal and throat swab specimens (JAMA)
• Four methods for monitoring SARS-CoV-2 and influenza A virus activity in schools (JAMA)
• Efficacy and safety of Baricitinib for the treatment of hospitalized adults with COVID-19 (EJMR)
• A synbiotic preparation (SIM01) for post-acute COVID-19 syndrome in Hong Kong (The Lancet)
• Consistent absence of cerebrospinal fluid biomarker abnormalities in patients with neurocognitive post-COVID complications (JID)
• Risk of new-onset long COVID following reinfection with SARS-CoV-2 (OFID)
• Contribute to our MicrobeTV fundraiser at PWB
• Dr. Griffin’s COVID treatment summary (pdf)
• Timestamps by Jolene. Thanks!

Intro music is by Ronald Jenkees

Send your questions for Dr. Griffin to [email protected]